Singular
European early-stage venture fund that led Apoha's £26.7m round.
Last refreshed: 7 June 2026 · Appears in 1 active topic
Timeline for Singular
led the Apoha £26.7m round
UK Startups and Innovation: Apoha bets £26.7m on lab data- What is Singular VC and where is it based?
- Singular is a Paris-based venture capital firm that invests in early and growth-stage technology companies across Europe, with a focus on AI, software, and data infrastructure.Source: Singular
- Which UK company did Singular VC lead a round for in 2026?
- Singular led the £26.7m funding round for Apoha, a London-based clinical and laboratory data platform company, in June 2026.Source: event
Background
Singular is a Paris-headquartered venture capital firm that backs early-stage and growth-stage technology companies across Europe. It invests primarily in software, artificial intelligence, and data-infrastructure businesses, with a portfolio concentrated on companies that embed proprietary data workflows into industries resistant to off-the-shelf AI tooling. The firm is sector-agnostic in practice but has developed particular depth in life-sciences software, fintech, and enterprise SaaS.
In June 2026, Singular led the £26.7m ($36m) funding round for Apoha, a London company building an end-to-end data platform for clinical and laboratory environments. The round also included Seedcamp, Draper Associates, Redalpine, and an Innovate UK grant alongside the equity, creating a mixed public-private cap table that has become increasingly common in UK life-sciences software.
Singular's lead role in the Apoha round reflects growing European VC interest in laboratory informatics as a wedge into healthcare data infrastructure. The firm competes for deals against US-originated firms that have opened London and Paris offices, and its participation signals continued conviction in UK-headquartered technical founders despite post-Brexit talent friction.